Page 51 - Read Online

Nasr et al. Metab Target Organ Damage 2023;3:19 https://dx.doi.org/10.20517/mtod.2023.20 Page 17 of 17

2007;47:412-7. DOI
169. Rocha ALL, Faria LC, Guimarães TCM, et al. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome:
systematic review and meta-analysis. J Endocrinol Invest 2017;40:1279-88. DOI
170. Jones H, Sprung VS, Pugh CJ, et al. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of
hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin
resistance. J Clin Endocrinol Metab 2012;97:3709-16. DOI
171. Kim S, Kwon H, Park JH, et al. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver
disease. BMC Gastroenterol 2012;12:69. DOI PubMed PMC
172. Nikolaenko L, Jia Y, Wang C, et al. Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats.
Endocrinology 2014;155:417-28. DOI PubMed PMC
173. Senmaru T, Fukui M, Okada H, et al. Testosterone deficiency induces markedly decreased serum triglycerides, increased small dense
LDL, and hepatic steatosis mediated by dysregulation of lipid assembly and secretion in mice fed a high-fat diet. Metabolism
2013;62:851-60. DOI
174. Pericleous M, Kelly C, Wang T, Livingstone C, Ala A. Wolman's disease and cholesteryl ester storage disorder: the phenotypic
spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol 2017;2:670-9. DOI
175. Polyzos SA, Perakakis N, Mantzoros CS. Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of
adiponectin and/or leptin replacement. Metabolism 2019;96:66-82. DOI PubMed
176. Di Filippo M, Moulin P, Roy P, et al. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite
metabolic differences in congenital hypocholesterolemia. J Hepatol 2014;61:891-902. DOI
177. Bernstein DL, Hülkova H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: review of the findings in 135 reported patients
with an underdiagnosed disease. J Hepatol 2013;58:1230-43. DOI
178. Burton BK, Balwani M, Feillet F, et al. A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency. N Engl J Med
2015;373:1010-20. DOI